List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine (PM) Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Personalized Diagnostics
1.2.3 Personalized Therapies
1.2.4 Personalized Nutrition & Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicine (PM) Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine (PM) Solution Market Perspective (2017-2028)
2.2 Personalized Medicine (PM) Solution Growth Trends by Region
2.2.1 Personalized Medicine (PM) Solution Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Personalized Medicine (PM) Solution Historic Market Size by Region (2017-2022)
2.2.3 Personalized Medicine (PM) Solution Forecasted Market Size by Region (2023-2028)
2.3 Personalized Medicine (PM) Solution Market Dynamics
2.3.1 Personalized Medicine (PM) Solution Industry Trends
2.3.2 Personalized Medicine (PM) Solution Market Drivers
2.3.3 Personalized Medicine (PM) Solution Market Challenges
2.3.4 Personalized Medicine (PM) Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicine (PM) Solution Players by Revenue
3.1.1 Global Top Personalized Medicine (PM) Solution Players by Revenue (2017-2022)
3.1.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Players (2017-2022)
3.2 Global Personalized Medicine (PM) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicine (PM) Solution Revenue
3.4 Global Personalized Medicine (PM) Solution Market Concentration Ratio
3.4.1 Global Personalized Medicine (PM) Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine (PM) Solution Revenue in 2021
3.5 Personalized Medicine (PM) Solution Key Players Head office and Area Served
3.6 Key Players Personalized Medicine (PM) Solution Product Solution and Service
3.7 Date of Enter into Personalized Medicine (PM) Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine (PM) Solution Breakdown Data by Type
4.1 Global Personalized Medicine (PM) Solution Historic Market Size by Type (2017-2022)
4.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Type (2023-2028)
5 Personalized Medicine (PM) Solution Breakdown Data by Application
5.1 Global Personalized Medicine (PM) Solution Historic Market Size by Application (2017-2022)
5.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Personalized Medicine (PM) Solution Market Size (2017-2028)
6.2 North America Personalized Medicine (PM) Solution Market Size by Type
6.2.1 North America Personalized Medicine (PM) Solution Market Size by Type (2017-2022)
6.2.2 North America Personalized Medicine (PM) Solution Market Size by Type (2023-2028)
6.2.3 North America Personalized Medicine (PM) Solution Market Share by Type (2017-2028)
6.3 North America Personalized Medicine (PM) Solution Market Size by Application
6.3.1 North America Personalized Medicine (PM) Solution Market Size by Application (2017-2022)
6.3.2 North America Personalized Medicine (PM) Solution Market Size by Application (2023-2028)
6.3.3 North America Personalized Medicine (PM) Solution Market Share by Application (2017-2028)
6.4 North America Personalized Medicine (PM) Solution Market Size by Country
6.4.1 North America Personalized Medicine (PM) Solution Market Size by Country (2017-2022)
6.4.2 North America Personalized Medicine (PM) Solution Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Personalized Medicine (PM) Solution Market Size (2017-2028)
7.2 Europe Personalized Medicine (PM) Solution Market Size by Type
7.2.1 Europe Personalized Medicine (PM) Solution Market Size by Type (2017-2022)
7.2.2 Europe Personalized Medicine (PM) Solution Market Size by Type (2023-2028)
7.2.3 Europe Personalized Medicine (PM) Solution Market Share by Type (2017-2028)
7.3 Europe Personalized Medicine (PM) Solution Market Size by Application
7.3.1 Europe Personalized Medicine (PM) Solution Market Size by Application (2017-2022)
7.3.2 Europe Personalized Medicine (PM) Solution Market Size by Application (2023-2028)
7.3.3 Europe Personalized Medicine (PM) Solution Market Share by Application (2017-2028)
7.4 Europe Personalized Medicine (PM) Solution Market Size by Country
7.4.1 Europe Personalized Medicine (PM) Solution Market Size by Country (2017-2022)
7.4.2 Europe Personalized Medicine (PM) Solution Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size (2017-2028)
8.2 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Type
8.2.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Personalized Medicine (PM) Solution Market Share by Type (2017-2028)
8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Application
8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Personalized Medicine (PM) Solution Market Share by Application (2017-2028)
8.4 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region
8.4.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Personalized Medicine (PM) Solution Market Size (2017-2028)
9.2 Latin America Personalized Medicine (PM) Solution Market Size by Type
9.2.1 Latin America Personalized Medicine (PM) Solution Market Size by Type (2017-2022)
9.2.2 Latin America Personalized Medicine (PM) Solution Market Size by Type (2023-2028)
9.2.3 Latin America Personalized Medicine (PM) Solution Market Share by Type (2017-2028)
9.3 Latin America Personalized Medicine (PM) Solution Market Size by Application
9.3.1 Latin America Personalized Medicine (PM) Solution Market Size by Application (2017-2022)
9.3.2 Latin America Personalized Medicine (PM) Solution Market Size by Application (2023-2028)
9.3.3 Latin America Personalized Medicine (PM) Solution Market Share by Application (2017-2028)
9.4 Latin America Personalized Medicine (PM) Solution Market Size by Country
9.4.1 Latin America Personalized Medicine (PM) Solution Market Size by Country (2017-2022)
9.4.2 Latin America Personalized Medicine (PM) Solution Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size (2017-2028)
10.2 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Type
10.2.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Personalized Medicine (PM) Solution Market Share by Type (2017-2028)
10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Application
10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Personalized Medicine (PM) Solution Market Share by Application (2017-2028)
10.4 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country
10.4.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 2bPrecise
11.1.1 2bPrecise Company Details
11.1.2 2bPrecise Business Overview
11.1.3 2bPrecise Personalized Medicine (PM) Solution Introduction
11.1.4 2bPrecise Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.1.5 2bPrecise Recent Developments
11.2 OneOme
11.2.1 OneOme Company Details
11.2.2 OneOme Business Overview
11.2.3 OneOme Personalized Medicine (PM) Solution Introduction
11.2.4 OneOme Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.2.5 OneOme Recent Developments
11.3 TIGAR Health- IR2Dx
11.3.1 TIGAR Health- IR2Dx Company Details
11.3.2 TIGAR Health- IR2Dx Business Overview
11.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Introduction
11.3.4 TIGAR Health- IR2Dx Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.3.5 TIGAR Health- IR2Dx Recent Developments
11.4 Kailos Genetics
11.4.1 Kailos Genetics Company Details
11.4.2 Kailos Genetics Business Overview
11.4.3 Kailos Genetics Personalized Medicine (PM) Solution Introduction
11.4.4 Kailos Genetics Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.4.5 Kailos Genetics Recent Developments
11.5 Syapse Inc
11.5.1 Syapse Inc Company Details
11.5.2 Syapse Inc Business Overview
11.5.3 Syapse Inc Personalized Medicine (PM) Solution Introduction
11.5.4 Syapse Inc Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.5.5 Syapse Inc Recent Developments
11.6 Karius
11.6.1 Karius Company Details
11.6.2 Karius Business Overview
11.6.3 Karius Personalized Medicine (PM) Solution Introduction
11.6.4 Karius Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.6.5 Karius Recent Developments
11.7 Astarte Medical
11.7.1 Astarte Medical Company Details
11.7.2 Astarte Medical Business Overview
11.7.3 Astarte Medical Personalized Medicine (PM) Solution Introduction
11.7.4 Astarte Medical Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.7.5 Astarte Medical Recent Developments
11.8 Fabric Genomics, INC.
11.8.1 Fabric Genomics, INC. Company Details
11.8.2 Fabric Genomics, INC. Business Overview
11.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Introduction
11.8.4 Fabric Genomics, INC. Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.8.5 Fabric Genomics, INC. Recent Developments
11.9 Orion Health
11.9.1 Orion Health Company Details
11.9.2 Orion Health Business Overview
11.9.3 Orion Health Personalized Medicine (PM) Solution Introduction
11.9.4 Orion Health Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.9.5 Orion Health Recent Developments
11.10 2B Precise
11.10.1 2B Precise Company Details
11.10.2 2B Precise Business Overview
11.10.3 2B Precise Personalized Medicine (PM) Solution Introduction
11.10.4 2B Precise Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.10.5 2B Precise Recent Developments
11.11 Fabric Genomics
11.11.1 Fabric Genomics Company Details
11.11.2 Fabric Genomics Business Overview
11.11.3 Fabric Genomics Personalized Medicine (PM) Solution Introduction
11.11.4 Fabric Genomics Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.11.5 Fabric Genomics Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Personalized Medicine (PM) Solution Introduction
11.12.4 Pfizer Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.12.5 Pfizer Recent Developments
11.13 Gene 42
11.13.1 Gene 42 Company Details
11.13.2 Gene 42 Business Overview
11.13.3 Gene 42 Personalized Medicine (PM) Solution Introduction
11.13.4 Gene 42 Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.13.5 Gene 42 Recent Developments
11.14 IBM Watson Health
11.14.1 IBM Watson Health Company Details
11.14.2 IBM Watson Health Business Overview
11.14.3 IBM Watson Health Personalized Medicine (PM) Solution Introduction
11.14.4 IBM Watson Health Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.14.5 IBM Watson Health Recent Developments
11.15 Philips Healthcare
11.15.1 Philips Healthcare Company Details
11.15.2 Philips Healthcare Business Overview
11.15.3 Philips Healthcare Personalized Medicine (PM) Solution Introduction
11.15.4 Philips Healthcare Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.15.5 Philips Healthcare Recent Developments
11.16 Medtronic
11.16.1 Medtronic Company Details
11.16.2 Medtronic Business Overview
11.16.3 Medtronic Personalized Medicine (PM) Solution Introduction
11.16.4 Medtronic Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.16.5 Medtronic Recent Developments
11.17 Nanthealth
11.17.1 Nanthealth Company Details
11.17.2 Nanthealth Business Overview
11.17.3 Nanthealth Personalized Medicine (PM) Solution Introduction
11.17.4 Nanthealth Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.17.5 Nanthealth Recent Developments
11.18 Navican
11.18.1 Navican Company Details
11.18.2 Navican Business Overview
11.18.3 Navican Personalized Medicine (PM) Solution Introduction
11.18.4 Navican Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.18.5 Navican Recent Developments
11.19 N-of-One
11.19.1 N-of-One Company Details
11.19.2 N-of-One Business Overview
11.19.3 N-of-One Personalized Medicine (PM) Solution Introduction
11.19.4 N-of-One Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.19.5 N-of-One Recent Developments
11.20 PierianDx
11.20.1 PierianDx Company Details
11.20.2 PierianDx Business Overview
11.20.3 PierianDx Personalized Medicine (PM) Solution Introduction
11.20.4 PierianDx Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.20.5 PierianDx Recent Developments
11.21 Sunquest Information System
11.21.1 Sunquest Information System Company Details
11.21.2 Sunquest Information System Business Overview
11.21.3 Sunquest Information System Personalized Medicine (PM) Solution Introduction
11.21.4 Sunquest Information System Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.21.5 Sunquest Information System Recent Developments
11.22 Tempus
11.22.1 Tempus Company Details
11.22.2 Tempus Business Overview
11.22.3 Tempus Personalized Medicine (PM) Solution Introduction
11.22.4 Tempus Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.22.5 Tempus Recent Developments
11.23 Novartis
11.23.1 Novartis Company Details
11.23.2 Novartis Business Overview
11.23.3 Novartis Personalized Medicine (PM) Solution Introduction
11.23.4 Novartis Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.23.5 Novartis Recent Developments
11.24 Translational Software
11.24.1 Translational Software Company Details
11.24.2 Translational Software Business Overview
11.24.3 Translational Software Personalized Medicine (PM) Solution Introduction
11.24.4 Translational Software Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.24.5 Translational Software Recent Developments
11.25 Biocrates Life Sciences AG
11.25.1 Biocrates Life Sciences AG Company Details
11.25.2 Biocrates Life Sciences AG Business Overview
11.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Introduction
11.25.4 Biocrates Life Sciences AG Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.25.5 Biocrates Life Sciences AG Recent Developments
11.26 Nanostring Technologies
11.26.1 Nanostring Technologies Company Details
11.26.2 Nanostring Technologies Business Overview
11.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Introduction
11.26.4 Nanostring Technologies Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.26.5 Nanostring Technologies Recent Developments
11.27 Thermo Fisher Scientific
11.27.1 Thermo Fisher Scientific Company Details
11.27.2 Thermo Fisher Scientific Business Overview
11.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Introduction
11.27.4 Thermo Fisher Scientific Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.27.5 Thermo Fisher Scientific Recent Developments
11.28 Quest Diagnostics Incorporated
11.28.1 Quest Diagnostics Incorporated Company Details
11.28.2 Quest Diagnostics Incorporated Business Overview
11.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Introduction
11.28.4 Quest Diagnostics Incorporated Revenue in Personalized Medicine (PM) Solution Business (2017-2022)
11.28.5 Quest Diagnostics Incorporated Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
